MedTrace Logo

Predictors of Parkinson's Disease Progression

NCT04062279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-10

No results posted yet for this study

Summary

it is a prospective longitudinal observational study, aiming to to identify clinical, and biochemical baseline predictors of motor and non-motor PD progression in sample of Egyptian patients. it measures the baseline motor, non-motor, biochemical and imaging characteristics at enrollment and its relation to PD progression over 3 years

Conditions

  • Parkinson Disease
  • Cognitive Dysfunction
  • Biomarkers

Interventions

DIAGNOSTIC_TEST

serum alpha synuclein autoantibodies, motor and non motor scales

measuring serum alpha synuclein autoantibodies by ELIZA at baseline assessment

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ali Shalash, professor · Ain Shams Univeristy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2024-04-30
Completion
2024-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04062279 on ClinicalTrials.gov